Healthcare -
Biotechnology - NASDAQ - US
$ 47.58
-3.14 %
$ 3.57 B
Market Cap
-12.69
P/E
AKRO - OPERATING INCOME
Operating Income AKRO - Akero Therapeutics, Inc.
-173 M
LAST VALUE
-30.90%
2 YEAR CAGR
-65.85%
5 YEAR CAGR
0.00%
10 YEAR CAGR